Vivos Therapeutics Inc Market Cap ($2.21 Million)
Market Cap & Net Worth: Vivos Therapeutics Inc (VVOS)
Vivos Therapeutics Inc market cap. Vivos Therapeutics Inc (NASDAQ:VVOS) has a market capitalization of $2.21 Million ($2.21 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29925 globally and #6111 in its home market, demonstrating a -16.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vivos Therapeutics Inc's stock price $0.11 by its total outstanding shares 20118023 (20.12 Million). Also see Vivos Therapeutics Inc (VVOS) cash conversion ratio for how efficiently the company converts equity into cash flow.
Vivos Therapeutics Inc Market Cap History (2020–2026)
Vivos Therapeutics Inc market cap history from 2020 to 2026. Data shows change from $2.97 Billion to $2.21 Million (-72.54% CAGR). Check VVOS stock price for real-time trading data and today's change.
Index Memberships
Vivos Therapeutics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #864 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2768 of 3165 |
Weight: Vivos Therapeutics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vivos Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vivos Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Vivos Therapeutics Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.34x
Vivos Therapeutics Inc's market cap is 2.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.97 Billion | $13.07 Million | -$12.06 Million | 227.49x | N/A |
| 2021 | $1.13 Billion | $16.89 Million | -$20.29 Million | 67.02x | N/A |
| 2022 | $202.19 Million | $16.02 Million | -$23.84 Million | 12.62x | N/A |
| 2023 | $250.27 Million | $13.80 Million | -$13.58 Million | 18.13x | N/A |
| 2024 | $86.31 Million | $15.03 Million | -$11.14 Million | 5.74x | N/A |
| 2025 | $40.84 Million | $17.44 Million | -$21.23 Million | 2.34x | N/A |
Competitor Companies of VVOS by Market Capitalization
Companies near Vivos Therapeutics Inc in the global market cap rankings as of November 5, 2026. Also see Vivos Therapeutics Inc assets under control for a full breakdown of the balance sheet.
Key companies related to Vivos Therapeutics Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Vivos Therapeutics Inc (2020–2026)
Market capitalization of Vivos Therapeutics Inc from 2020 to today. Between 2020 and today, Vivos Therapeutics Inc's market cap moved from $2.97 Billion to $ 2.21 Million, with a yearly change of -72.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.21 Million | -94.59% |
| 2025 | $40.84 Million | -52.68% |
| 2024 | $86.31 Million | -65.51% |
| 2023 | $250.27 Million | +23.78% |
| 2022 | $202.19 Million | -82.13% |
| 2021 | $1.13 Billion | -61.93% |
| 2020 | $2.97 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Vivos Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.21 Million USD |
| MoneyControl | $2.21 Million USD |
| MarketWatch | $2.21 Million USD |
| marketcap.company | $2.21 Million USD |
| Reuters | $2.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnorma… Read more